Scientists test Triple-Drug cocktails in fight against advanced cancer
NCT ID NCT01187199
Summary
This early-stage trial aims to find the safest and most effective doses of new drug combinations for people with advanced cancer that has not responded to standard treatments. Researchers are testing two core drugs (bevacizumab and temsirolimus) paired with one of three other cancer drugs. The main goal is to determine the highest dose patients can tolerate without severe side effects, while also checking if the combinations help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.